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Case Presentation
A 40-year-old woman was admitted to the metabolic ward of
St. Vincent's Hospital in Dublin. Two years previously, she had
been admitted to the genitourinary ward because of left renal
colic. At that time, an i.v. urogram showed bilateral spotty neph-
rocalcinosis in kidneys of normal size, and a solitary renal cyst
was visible on the right side. Laboratory findings disclosed the
following: hematocnt, 47%, blood urea nitrogen (BUN), 10
mg/100 ml; serum sodium, 141 mEq; serum potassium, 4.4 mEq;
serum chloride, 104 mEq; serum bicarbonate, 26 mEq/liter;
serum uric acid, 3.8 mg; total calcium concentration from a
single sample of serum, 10.7 mg (normal, 9.0 to 10.6 mg, 95%
limits) and ionized serum calcium, 5.5 mg/l00 ml (normal, 4.1 to
5.3 mg/100 ml, 95% limits); urine calcium, 262 mg/24 hr (normal
< 250 mg124 hr); the urine sediment was unremarkable, and a
culture of the urine was sterile.
One year later, the patient entered the outpatient clinic with
an episode of right renal colic. On this occasion, total serum
calcium concentration was 10.3 mg and ionized serum calcium
was 5.5 mg/lOO ml; a simultaneous parathyroid hormone (iPTH)
level was 0.18 nglml as measured by radioimmunoassay using
the Slatopolsky carboxy-terminal specific antiserum (normal
range, 0.0 to 0.33 ng/ml). The findings of a second i.v. urogram
indicated no change in kidney status; there was no evidence of
pelvi-ureteric dilatation. The patient was admitted subsequently
to the metabolic ward for investigation of hypercalciuria, neph-
rocalcinosis, and marginal hypercalcemia, although iPTH level
was apparently normal.
On admission the patient had no history of excessive ingestion
of milk, oral alkali preparations, or vitamin supplements. Her
mother and brother each had had one episode of renal colic in
the past. Physical examination was unremarkable with blood
pressure of 110/70 mm Hg. Laboratory findings revealed the
following: hematocrit, 43%; white blood cell count, 6700 mm3;
sedimentation rate, 1 mm/hr; urine protein was absent; EKG
was normal; chest radiogram showed healed tuberculous foci;
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radiograms of the hands were normal; BUN, 12 mg/l00 ml;
serum sodium, 142 mEq; serum potassium, 4 mEq; serum chlor-
ide, 107 mEq; serum bicarbonate, 23.5 mEq/liter; total protein,
7.2 g; serum albumin, 4.6 gf 100 ml; alkaline phosphatase, 7.4
King-Armstrong U; serum creatinine, 0.9 mg/lOU ml. For 4 days,
a fixed diet that contained 500 mg of calcium and 1 g of phos-
phorus was given to the patient; laboratory values for serum
taken on the mornings of days 3 and 4 were; total calcium, 9.9
and 10.0 mg; ionized calcium, 5.2 and 5.1 mg; phosphate was
2.7 mg/lOO ml on both mornings (normal, 2.6 to 4.2 mgJlOO ml).
The following additional laboratory values were obtained on
mornings 3 and 4; urinary calcium, 323 and 289 mg124 hr; per-
cent of tubular reabsorption of phosphate, 74.5 and 76.8% (nor-
mal, 83 to 87%). Serum iPTH levels were 0.57, 0.35, and 0.55
ngIml. The serum level of 25-hydroxy vitamin D was 6.9 ng/ml
(normal, 11.8 4.0 ng/ml).
In spite of five normal values for total serum calcium obtained
in the fasting state (mean, 10 mg/lOO ml), it was decided to refer
the patient for surgical exploration of the neck because her
mean ionized serum calcium concentration of 5.4 mg/l00 ml was
at the upper 95% limit of normal, and because three of four
iPTH values were elevated. Serum taken on the morning of para-
thyroid surgery showed total serum calcium concentration to be
10.5 mg and ionized serum calcium, 5.7 mg/lOU ml. The 24-hour
urinary calcium excretion was 349 mg. The surgical procedure
revealed an enlarged parathyroid gland. The gland, weighing
360 mg, was removed; the tissue was adenomatous on histologic
examination. Two other parathyroid glands were biopsied and
proved to be normal. The patient's postoperative course was
uneventful. Review after 5 months revealed a total serum cal-
cium concentration of 8.8 mg, an ionized serum calcium con-
centration of 5 mg/lOU ml, a urinary calcium excretion of 184
mg/day, and a serum iPTH level of 0.14 ng/ml.
Discussion
DR. FRANCIS P. MULDOWNEY (Research Profes-
sor of Medicine, University College, and Physician-
in-Charge, Metabolism and Renal Unit, St. Vin-
cent's Hospital, Dublin): I believe the diagnostic
This installment of Nephrology Forum was held at Mater Miser-
icordiae Hospital, Dublin, Ireland on March 16, 1979.
Presentation of the Forum is made possible by grants from
Hoechst-Roussel Pharmaceuticals Inc., Smith Kline & French
Laboratories, G. D. Searle & Co., Warner-Lambert Pharmaceu-
tical Division, Burroughs Welicome Company, Geigy Pharma-
ceuticals Inc., Ciba Pharmaceuticals Inc., and Boehringer In-
gelheim Ltd.
0085-2538/79/0016-0637 $02.40
© 1979 by the International Society of Nephrology
The Nephro!og Forum is designed to relate
the principles of basic science to clinical prob-
lems in nephrology.
Editors
JORDAN J. CohEN
JOHN T. HARRINOTON
JEROME P. KA55IRER
New England Medical Center Hospital
Boston, Massachusetts
638 Nephrology Forum
problem of renal stone disease is best approached,
not by a long and learned list of causes, but by re-
membering the relative frequency of the most im-
portant ones. In 1970, Yendt [1] provided a most
helpful breakdown of his series of 439 patients with
renal stone disease: he showed that 42% had idio-
pathic hypercalciuria, 11% had primary hyper-
parathyroidism, 8% had urinary infection, 5% had
uric acid stone, and 2% had cystinuria; no cause
was found in 24%. This is a convenient list to re-
member at the bedside and puts into perspective the
relative importance of, for example, infection/ob-
struction, which is a minor cause, and idiopathic
hypercalciuria, which is a major cause of renal
stone disease. One may note that more sophisti-
cated renal tubular disease, such as classical renal
tubular acidosis or medullary sponge kidney,
scarcely deserve mention. Nevertheless, a system-
atic approach to the diagnosis in each patient must
attempt to be reasonably comprehensive as well as
crudely practical; one must know each horse in the
race as well as the betting odds. Idiopathic hyper-
calciuria may be the "favorite"; but it may just oc-
casionally take second place to an outsider such as
milk-alkali syndrome!
With this in mind, Figure 1 sets out a sequence of
diagnostic steps using certain key techniques in the
order best calculated to give weight to the major
causes, while allowing necessary consideration to
the minor ones. The first question is whether hyper-
calciuria is present. If not, we move into a minor
pathway to consider causes such as infection/ob-
struction, urate stone, or cystinuria. Patients with
NO
Urate stone
Cystinuria
Infection
Obstruction
either of the latter two conditions frequently have a
familial history that is helpful, and laboratory data
such as serum uric acid concentration and results of
urinary amino acid chromatography enable one to
make the diagnosis. Infection, obstruction, urate
stone, or cystinuria are causal factors in some 15 to
20% of all patients with renal stone disease [1].
The presence of hypercalciuria may be docu-
mented in a number of ways. The standard indicator
is 24-hour urinary calcium excretion—upper limits
of normal are 300 mg in the male and 250 mg in the
female [2]. The patient under discussion today, a
female, had a 24-hour urinary calcium excretion in
excess of 250 mg on 2 successive days while receiv-
ing a diet that contained 500 mg of calcium. An ad-
ditional index of hypercalciuria is the fasting morn-
ing "spot" urine calcium concentration as it relates
to filtered calcium load (see Table 1). This measure-
ment has the great advantage of avoiding the cum-
bersome collection of total 24-hour volume, which
is prone to collection errors and the consequent var-
iability of results. For instance, a fasting urinary
calcium to creatinine concentration ratio or a uri-
nary calcium per 100 ml of glomerular filtrate that
exceeds 0.11 is likely to represent hypercalciuria.
The "spot" urine calcium to creatinine concentra-
tion ratio provides a useful screening test for the
busy nephrologist and may be repeated as often as
desired.
If hypercalciuria is present as in our patient
today, the next question is whether the serum cal-
cium concentration is elevated. If the serum cal-
cium concentration appears to be normal, and if no
Renal Stone
Hypercalciuria
24-hr urine
Fasting spot" urine
Oral Ca load test
YES
Serum total & ionized Ca
Normal High
Idiopathic hypercalciuria
Classical renal tubular acidosis
Medullary sponge kidney Serum i PTH
Normal or low High
Milk-alkali syndrome
Sarcoidosis Refer forVatamin D intoxication
Immobilization; Pagets parathyroid
exploration
Fig. 1. Suggested scheme of approach to diagnosis in renal stone disease based on presence or absence of hypercalciuria, hyper-
calcemia, and serum parathyroid hormone (iPTH) elevation.
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Table 1. Urinary and serum calcium (Ca) in the fasting state and following oral loading with Ca, 30mg/kg of body weight.
Idiopathic Control vs
Control hypercalciuria idiopathic
= 90 n = 18 hypercalciuria
Creatinine (Cr) clearance, mi/mm 106 16 103 17 NS
TotalserumCa,mg/IOOml Fasting
Post-loa&'
9.25 0.41
10.0 0.52
<0.02
9.35 0.36
10.24 0.48
<.001
NS
NS
Ionized serum Ca, mg/100 ml Fasting
Post-load
5.02 0.29
5.24 0.24
<0.2
4.86 0.21
5.16 0.31
<.005
NS
NS
Urine Ca,ing/100 ml GF Fasting
Post-load
0.07 0.051
0.241 0.069
<.001
0.149 0.078
0.355 0.084
<.001
<0.01
< 0.005
Urine Ca/Crratio Fasting
Post-load
0.068 0.044
0.233 0.077
<.001
0.149 0.076
0.354 0.069
<.001
<0.001
< 0.001
Urine Ca as percent filtered ionized Ca Fasting
Post-load
1.87 0.87
4.45 1.27
<.01
3.23 1.48
7.04 1.69
<.001
< 0.05
< 0.001
an denotes number of patients
bPost-load data refer to the collection period 3 to 4 hours following ingestion of the calcium.
GF denotes glomerular filtrate
other demonstrable cause is apparent, the diagnosis
of idiopathic hypercalciuria can be made with some
assurance. If the serum calcium concentration is
elevated, however, the alternate pathway of investi-
gation should be taken using iPTH level as a main
determinant of management. Note that this path-
way ends either with surgical neck exploration for a
parathyroid adenoma, or with evaluation directed
toward nonparathyroid causes of hypercalcemia,
most of which are reversible, such as milk-alkali
syndrome. Before proceeding along either route,
one must be reasonably certain that hypercalcemia
does or does not exist. If the wrong route is taken
because of incorrect or inadequate laboratory eval-
uation, the patient may receive inappropriate thera-
py. There are two classic examples of this problem:
administration of thiazide therapy for supposed
idiopathic hypercalciuria that is really undocu-
mented primary hyperparathyroidism; and fruitless
neck exploration and biopsy in a patient with nor-
mal parathyroid glands. I should mention one fur-
ther unfortunate consequence of the wrong decision
at this critical juncture. The definition and sub-
sequent investigation and classification of patients
who are predisposed to the formation of renal
stones may be unintentionally obscured, and incor-
rect assumptions may be made concerning etiology
and pathophysiology for each subgroup, unless
clear lines of distinction and definition are seen and
agreed to by all workers in the field. The techniques
that are available today were not available 10, 15, or
30 years ago when many of the standard investiga-
tions were made. [3, 4, 5]. At that time, conclusions
were based on values for total serum calcium or
perhaps ultrafilterable calcium concentration only.
It is now possible to measure the ionized fraction of
the calcium concentration by ion-specific electrodes
and the iPTH level by a sensitive radioimmunoas-
say; thus, the onus is on us to assess the value of
these data in the same critical fashion as was done
for the less revealing data relied on in the past.
Idiopathic hypercalciuria accounts for 42% of all
cases of renal stone disease [1]. Unfortunately, it
resembles the next most common cause, primary
hyperparathyroidism, in many ways. The critical
distinguishing feature between the two disorders is
the presence or absence of hypercalcemia: Both fre-
quently show hypercalciuria: both may show hypo-
phosphatemia with lowered tubular phosphate reab-
sorption; and to make difficulty doubly defiant, Coe
et al [6] have demonstrated that both may show ele-
vated immunoreactive serum iPTH levels. Our im-
mediate problem in this patient, therefore, is one
familiar to all nephrologists, that of differentiating
between idiopathic hypercalciuria and primary hy-
perparathyroidism. Since such differentiation is
achieved classically by the presence or absence of
hypercalcemia, we must devote some time to that
particular point.
Florid hypercalcemia is, of course, identified eas-
ily—that is, a serum calcium concentration above
11 mg/100 ml, which corresponds to the 99% con-
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fidence limit (+3 SD) of the normal range. Our con-
trol studies show that serum calcium values be-
tween 10.9 and 10.6 mg!l00 ml correspond to the 99
and 95% confidence limits, respectively, and thus
would be expected to occur in 2.5% of the normal
population; values between 10.5 and 10.2 mg/lOO ml
(+ 1 SD) would be expected in about one-sixth of the
population. "Hypercalcemia" or "normocalce-
mia" are, therefore, inappropriately absolutist terms
that should be defined rather by the levels of con-
fidence or degrees of doubt! We prefer not to
use the term "normocalcemia" and consider all val-
ues above 10 mg and below 11 mg/lOO ml to be in-
dicative of marginal hypercalcemia. These values
immediately suggest to us the following tactics: (1)
repeated, careful laboratory examination of sam-
ples taken in the fasting state and with minimal
venous stasis and (2) further corroboration by mea-
suring the ionized serum calcium concentration
with an ion-specific, flow-through electrode. In the
patient discussed today, the grand mean value for
total calcium concentration was 10.0 mg!100 ml—
less than 1 SD above the average normal level—
whereas the ionized serum calcium concentration
was more clearly elevated at 5.3 mg/l00 ml, or 2 SD
above the average normal value. This comparison
reflects accurately the relative values of the two
techniques in our experience [7]. In short, a margin-
al finding for total serum calcium concentration in
primary hyperparathyroidism appears to be more
easily defined, and with greater statistical con-
fidence, by measuring the ionized fraction of the
serum calcium concentration.
If significant hypercalcemia can be confirmed, the
'next question is whether it is of parathyroid or non-
parathyroid origin. The logical sequence leads to
measurement of serum iPTH level. We have used
Slatopoisky's excellent antiserum for some years,
and the results in the important group of patients
who have marginal primary hyperparathyroidism
are illustrated in Figure 2. In 1975 and 1976, we
originally defined the limits above which neck ex-
ploration should be advised. At that time, we felt
that an ionized serum calcium concentration above
5.6 mg/lOO ml, i.e., +3 SD, with a serum iPTH level
above the upper limit of normal, 0.33 ng/ml, should
be the proper conservative guidelines, which would
avoid inappropriate surgery in patients who did not
have primary hyperparathyroidism [71. With accu-
mulating experience, we have now lowered the limit
to 5.3 mg/lOO ml, i.e., +2 SD, for ionized serum cal-
cium concentration, provided that the iPTH level is
elevated. Twelve patients with values for total
—.—.—.—.—.-—.—.—.—.-t
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serum calcium of 10.9 mg/lOO ml or less—six, 10.4
mg/l00 ml or less—and ionized serum calcium of
5.3 mg/l00 ml or more have been referred for neck
exploration. In ten patients, iPTH level was avail-
able, and it was elevated in nine. In each patient,
the presence of primary hyperparathyroidism was
confirmed at surgery: adenoma was found in ten pa-
tients, and multiple hyperplasia was found in two.
It should be noted further that seven of the pa-
tients with idiopathic hypercalciuria continue to
show ionized serum calcium values at or above the
+ 1 SD level. Although iPTH levels are normal or
low in this group, one must accept the possibility
that these may represent primary hyperparathyroid-
ism of mild degree, which is undetectable by cur-
rent immunoassay techniques. Thus, it is possible
that all patients with idiopathic hypercalciuria re-
flect a spectrum of mild but currently undetectable
hyperparathyroidism. We do not, however, advo-
cate neck surgery in this group since hypercalciuria
can be easily controlled by oral chlorthalidone in
the majority of patients.
In the case of hypercalcemia that is not associat-
ed with hyperparathyroidism, as shown by normal
0
0.5 -
0.4 -
0
1.80
0
0
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0.3
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0
0
0
0.1
• I
• I
+2 SDMEANl_.•,
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—
5.5 6.5
Ionized serum Ca, mg/F 00 ml
Fig. 2. Relationship in renal stone disease of serum parathyroid
hormone (iPTH) to ionized serum calcium (Ca) values in patients
with marginal primary hyperparathyroidism (open circles) and
idiopathic hypercalciuria (closed circles). Mean +2 SD indicated
for ionized Ca. Total normal range indicated for iVFH. 'Margi-
nal" refers to proven primary hyperparathyroidism with serum
total Ca between 10 and 10.9 mg/l00 ml.
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or low iPTH levels (Fig. 1), the clinical history and
routine investigation should carefully exclude
known causes such as milk-alkali syndrome, Pa-
get's disease, prolonged immobilization, vitamin D
intoxication, and sarcoidosis. All of these may be
associated with hypercalcemia, which is often
rather fleeting and mild in character. Milk-alkali
syndrome represents a form of calcium-induced
renal tubular alkalosis with a high tubular bicarbo-
nate threshold [8, 9]. Vitamin D ingestion, like milk-
alkali intake, may not be admitted or even realized
by the patient, and measurements of serum 25-hy-
droxy vitamin D concentration may be necessary
[10]. Both vitamin D and milk-alkali ingestion are
associated with systemic alkalosis in contrast with
the acidosis and hyperchioremia that may be seen in
hyperparathyroidism [11]. The patient under dis-
cussion today showed a mild hyperchloremic acid-
osis, which was a helpful diagnostic indicator.
The mechanism of hypercalciuria in hyper-
calcemia is thought to be a simple increase in fil-
tered calcium load. An exception to this general
rule would be provided if glomerular filtration rate
(GFR) had decreased, as commonly happens in
chronic cases. Some have taken the view that pri-
mary hyperparathyroidism is also an exception be-
cause the effect of PTH-induced hypercalcemia to
increase the filtered load of calcium is thought to be
offset by a direct stimulating effect of the hormone
on tubular reabsorption [12]. It is difficult, however,
to find convincing data to support this conclusion in
the clinical sphere. In the patients studied by us
shown in Table 2, hypercalciuria was visible even in
those patients with primary hyperparathyroidism in
whom serum calcium concentration and filtered
load were only minimally elevated. This finding
held true both for the data derived from 24-hour
urine collections and for the data derived from fast-
ing morning urine specimens [13]. Thus, even if the
filtered calcium load is elevated to a minimal de-
gree, it is not compensated for by increased tubular
calcium reabsorption despite high circulating iPTH
levels. Primary hyperparathyroidism therefore re-
mains an important cause of hypercalciuria even in
patients with minimal hypercalcemia. Whether hy-
percalciuria in primary hyperparathyroidism at any
given calcium concentration is less than in other
causes of hypercalcemia may require further docu-
mentation. At this point, however, the argument be-
comes somewhat academic and scarcely relevant to
the differential diagnosis of clinical hypercalciuria.
Genuinely relevant, however, is the close resem-
blance of so-called "resorptive" hypercalciuria due
to primary hyperparathyroidism and "renal" hy-
percalciuria in the sense that both clearly show in-
creased fractional calcium excretion. Thus a renal
calcium "leak" becomes yet another point of simi-
larity between primary hyperparathyroidism and its
great simulator, idiopathic hypercalciuria.
If hypercalcemia is excluded, our diagnostic
scheme (Fig. 1) leads to the category of normocal-
cemic hypercalciuria of which idiopathic hyper-
calciuria is the most important member. Other
causes, such as classical or distal renal tubular aci-
dosis and medullary sponge kidney, are readily ex-
cluded by serum and urine acid-base measurements
Table 2. Urinary calcium (Ca) in relation to serum Ca concentration and parathyroid hormone (iPTH) level in primary
hyperparathyroidism and in idiopathic hypercalciuria.
Urine Serum
Total Ca Ionized Ca iPTHCcr5 Ca
mi/mm mg124 hrs mg/i00 ml mg/i 00 ml ng/ml
Hypercalcemic hyperparathyroidism mean
SD
NC
72.9
23.2
11
434
210
11
12.4
1.5
11
6.8
1.2
11
0.81
0.22
11
Marginal hyperparathyroidism mean
SD
N
94.6
25.4
12
329
98
14
10.5
0.2
14
5.7
0.3
14
0.71
0.34
12
Idiopathic hypercalciuria mean
SD
N
103
17
18
372
63
18
9.4
0.4
18
4.9
0.2
18
0.09
.07
17
Normal below 300 (male) 9.8 .9
below 250 (female)
4.7 .6
(± 2 SD)
0.15 .06
a Urinary Ca is seen to be elevated in all, including those patients with hyperparathyroidism who have minimal elevation of serum Ca
concentration (marginal hyperparathyroidism).b Ccr denotes creatinine clearance
n denotes number of patients.
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or by careful i. v. urographic examination for caliec-
tasis. The etiology of idiopathic hypercalciuria has
been a favorite topic of argument for some years
because the intestinal calcium hyperabsorption theo-
ry [5, 14, 15] has been opposed to the renal calcium
"leak" theory supported by Coe et al [6]. Based on
our recent measurements of fractional excretion of
filtered ionized calcium, we have concluded that all
patients with idiopathic hypercalciuria can be
shown to have a renal calcium leak [13]. Table 1
lists urine calcium expressed in three different ways
in relation to GFR or filtered calcium load. Com-
pared with normal control patients, the group of pa-
tients with idiopathic hypercalciuria excrete a high-
er proportion of filtered calcium. Most patients
show excessive fractional excretion even in the
fasting state. Almost all patients show this charac-
teristic in the period following oral calcium loading.
We have recently confirmed this post-load tubular
leak" pattern even in those patients with hyper-
calciuria who have the mildest degree of calcium
leak, as indicated by normal fasting urinary calcium
to creatinine concentration ratios [13]. This latter
group had previously been designated to be "ab-
sorptive" by Pak et al [15].
I should like to stress that we have looked care-
fully in our patients with idiopathic hypercalciuria
at serum calcium concentration following calcium
loading. The earlier data of Peacock, Knowles, and
Nordin [5] had suggested a greater increment in
serum calcium concentration in patients with
idiopathic hypercalciuria compared with control pa-
tients. This indeed has been one of the major argu-
ments adduced in favor of the intestinal hyper-
absorption theory [14, 15]. We have not, however,
found any difference in postabsorptive serum cal-
cium concentration between our two groups; both
control patients and patients with idiopathic hyper-
calciuria reached exactly similar concentrations of
total and, in particular, of ionized serum calcium
[13]. Thus, the sequence postulated by Pak et al
[15]— calcium hyperabsorption causing hyper-
calcemia, which suppresses PTH and thereby di-
minishes tubular calcium reabsorption—cannot be
sustained in view of the essential absence of relative
post-absorptive hypercalcemia. Neither can normal
or low values for serum iPTH (see Table 21)obtained
12 hours after the last meal in fasting patients with
hypercalciuria be reasonably related to a theoretical
post-prandial hypercalcemia. In retrospect, the pa-
tients thought to have idiopathic hypercalciuria by
Peacock, Knowles, and Nordin [5] included several
who initially were suspiciously hypercalcemic corn-
pared with controls and indeed overlapped the
range of 10 to 10.5 mg/100 ml, which includes many
of our patients with marginal primary hyper-
parathyroidism (see Table 2). It does not therefore
seem surprising that following oral calcium loading
the serum levels of such patients should show an
inordinate increase, as indeed our own data in simi-
lar patients with marginal hyperparathyroidism am-
ply confirm [13]. Once again, one may stress the im-
portance of careful preliminary exclusion of masked
primary hyperparathyroidism with marginal hy-
percalcemia from any apparent idiopathic hyper-
calciuria grouping before proceeding to make de-
ductions concerning intestinal or renal tubular
function. Of course, some degree of intestinal hy-
perabsorption does exist, and this has indeed been
demonstrated in external balance studies [16]. Dr.
John Ryan of our department (RYAN, personal com-
munication, 1979) has confirmed such a pattern us-
ing 45calcium in five of our patients with idiopathic
hypercalciuria. Hyperabsorption may, however, be
a compensation for renal calcium loss rather than an
initiating stimulus, as was pointed out by Jackson
and Doncaster in 1959 [17]. Our data are consistent
with this view.
To summarize so far, our data suggest strongly
that hypercalciuria in the idiopathic syndrome is
due to diminished renal tubular calcium reabsorp-
tion, or a renal "leak". We therefore agree essen-
tially with the concept supported by Coe et al [6],
with the important exception that we do not confirm
their postulate that such a leak gives rise to second-
ary hyperparathyroidism. In our experience to date,
all patients with genuinely normal calcium concen-
tration who had stone formation and hyper-
calciuria—that is, idiopathic hypercalciuria care-
fully defined—showed normal serum iPTH levels.
Those of our patients with hypercalciuria who
showed elevated iPTH levels also showed signifi-
cantly elevated serum concentration of ionized cal-
cium and were later shown at neck surgery to have
primary hyperparathyroidism.
Indeed, one must question seriously the assump-
tion that a mild chronic increase in urinary calcium
excretion causes a decrease in ionized serum cal-
cium concentration with a resulting increase in
serum iPTH levels [6]. McCarron et al [18] have re-
cently demonstrated that an increase in urinary cal-
cium to 300 mg/day on a chronic basis by oral so-
dium loading does not result in a decrease in ionized
serum calcium concentration or an increase in iPTH
level. The earlier study of Coe et al [6] had demon-
strated that an increase in urinary calcium concen-
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tration could be induced by daily furosemide admin-
istration for 1 week. Under these circumstances,
iPTH levels increased, but it is not clear that the
increase in urinary calcium excretion was the re-
sponsible factor or even that hypocalcemia result-
ed. A decrease in extracellular fluid volume, for in-
stance, may have been important. Rosenbaum et a!
[19] have shown that an increase in antidiuretic hor-
mone excretion, such as might be expected follow-
ing furosemide administration, is accompanied by
increasing iPTH plasma levels. The data of McCar-
ron et al [18] are important because they showed
that an increase in urinary calcium excretion pro-
duced by sodium loading with increased extra-
cellular fluid volume resulted in no change in ion-
ized serum calcium concentration and a slight de-
crease in iPTH level.
The mechanism of the renal tubular "leak" of
calcium in idiopathic hypercalciuria must at present
remain open to speculation. Elevated serum con-
centrations of 1,25-dihydroxy vitamin D have been
reported [20] and may represent either a primary
defect or one generated by the phosphate depletion
that results from the well-described defect in tubu-
lar phosphate reabsorption. Alternatively, as men-
tioned earlier, a spectrum of underlying primary hy-
perparathyroidism of varying mildness or severity
may induce both renal phosphate loss and excess
generation of 1,25-dihydroxy vitamin D in renal pa-
renchyma. Whatever the ultimate defect may be,
the net effect appears as hypercalciuria apparently
due to diminished tubular calcium reabsorption,
with intestinal hyperabsorption acting in a com-
pensatory fashion only. In discussing this patient
for the Nephrology Forum, it seems appropriate to
rescue idiopathic hypercalciuria from its status as a
plaything of the gastroenterologists and to bring it
back firmly to the kidney where it surely belongs!
Questions and Answers
DR. JOHN DONOHOE (Consultant Nephrolo gist,
Mater Misericordiae Hospital, Dublin): Thank you
very much Dr. Muldowney for that eloquent dis-
cussion. Your stirring conclusion is dear to the
heart of any nephrologist! I should like to begin the
question and answer period by asking a general
question. As you know, urinary calcium excretion
is diminished by administration of thiazides in pa-
tients with idiopathic hypercalciuria. Coe has
shown that serum iPTH levels, which are signifi-
cantly higher than controls prior to thiazide thera-
py, return virtually to normal with thiazides [6]. He
interpreted these findings to be consistent with sec-
ondary hyperparathyroidism consequent to a pri-
mary renal leak of calcium. In regard to the patient
presented today, I wonder if you might have consid-
ered carrying out a therapeutic trial of thiazides to
delineate further the mechanism of the hyper-
calciuria?
In addition, do you know of any studies that fo-
cus on "autonomy" of the parathyroid glands in
idiopathic hypercalciuria? Have there been any ef-
forts, for example, to determine by calcium infusion
whether hyperparathyroidism is primary or second-
ary in such patients?
DR. F. P. MULDOWNEY: The difficulty about sup-
pression tests is that not only can secondary hyper-
parathyroidism be suppressed, but many patients
with primary hyperparathyroidism can ultimately
be suppressed as well. Potts et al [21] have shown
that many patients with adenomatous parathyroid
tissue have decreased plasma iPTH levels following
calcium infusion, and we have confirmed that find-
ing [7]. We have shown that, both in patients with
secondary hyperparathyroidism of intestinal malab-
sorption and in those with adenomas or primary hy-
perparathyroidism, a calcium infusion will suppress
iPTH levels. For that reason, it has always seemed
to me to be unsatisfactory to use suppressibility as
an index to determine whether a given patient has
primary or secondary hyperparathyroidism. The
data obtained by Coe et al [6], I feel, can be inter-
preted as indicating primary hyperparathyroidism
as easily as secondary hyperparathyroidism, al-
though the latter was the chosen interpretation of
the study. The same rationale applies to the recent
data of Bordier et al [22] in which sufficient 25-hy-
droxy vitamin D was given orally to raise serum cal-
cium concentration. They found that in approxi-
mately one-half of the patients the iPTH level was
suppressible by that technique; in the other half it
was not, but the significance of this finding is not
really clear.
DR. J. T. HARRINGTON: Dr. Muldowney, I have a
problem in understanding the precise reasons for
hypercalciuria in patients with so-called normocal-
cemic hyperparathyroidism. It has been argued that
patients with primary hyperparathyroidism are hy-
percalciuric because of the hypercalcemia and the
consequent increased filtered load of calcium; the
latter is thought to override the direct tubular effect
of parathyroid hormone, namely, to increase distal
calcium reabsorption. The patient presented today
had a normal ionized serum calcium concentration
at times, yet she was still hypercalciuric. How do
you explain this?
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DR. F. P. MULDOWNEY: This is an important
point. As I mentioned earlier, we do know from mi-
cropuncture studies that the effect of PTH on the
kidney is to promote the tubular reabsorption of cal-
cium. This effect has been widely extrapolated in
the clinical sphere to suggest that those patients
who are hypercalcemic from hyperparathyroidism
have a lower urinary calcium excretion than those
who are hypercalcemic to the same degree from
other causes. The data to support this hypothesis
are amazingly scanty, so scanty that I cannot find
any. Our population is in many ways an ideal group
in which to conduct such a study because primary
hyperparathyroidism is being defined in a group
whose excess filtered load is very small because
their degree of hypercalcemia is very minor (see
Table 2); if the effect of a high PTH level in promot-
ing tubular reabsorption were ever going to over-
come the effect of a high filtered load, it should do it
in this group. In fact, hypercalciuria is a feature in a
significant number of patients in the group; thus,
they are hypercalciuric even at a time when the in-
crease in the filtered load is minimal. I think this
indicates that even in the very marginal, minimally
hypercalcemic patient with primary hyperpara-
thyroidism, hypercalciuria is still a feature. There-
fore, the general rule holds that hypercalcemia from
any cause, including primary hyperparathyroidism,
is associated with hypercalciuria. The only ex-
ception to that would be a patient who has a signifi-
cant reduction in GFR.
DR. BRENDAN DUFFY (Consultant Nephrolo gist,
Regional Hosptial, Gaiway): First, could you com-
ment on the level of serum phosphate in your pa-
tients with idiopathic hypercalciuria? As you
know, phosphate depletion produces a marked hy-
percalciuria. Second, is there any evidence of "in-
complete" renal tubular acidosis in these patients,
and if so, what is its relationship to PTH?
DR. F. P. MULDOWNEY: The presence of phos-
phate depletion in idiopathic hypercalciuria is inter-
esting because, as I mentioned earlier, this condi-
tion resembles primary hyperparathyroidism. In-
deed, phosphate depletion may be the primary
defect in idiopathic hypercalciuria. As you noted, it
tends to cause hypercalciuria, perhaps directly or
perhaps because it promotes the metabolism of vita-
min D rapidly from 25-hydroxy to I ,25-dihydroxy
vitamin D. Phosphate depletion is a stimulator of
the 1-hydroxylase system in the kidney. As a result,
you would expect to find a high concentration of
1,25-dihydroxy vitamin D in the serum, and indeed
this has been found in the syndrome of idiopathic
hypercalciuria [20]. On the other hand, it may be
that 1 ,25-dihydroxy vitamin D itself causes hyper-
calciuria, and this may be the reason why many of
these patients have a mild compensatory gastroin-
testinal calcium hyperabsorption. To answer your
second question, we have shown renal tubular aci-
dosis in patients with marginal hyperparathyroidism
[7], and we think this is due to the excess circulating
PTH levels. In the group of patients with idiopathic
hypercalciuria, we have not seen a significant sys-
temic acidosis except with a few patients who had a
rather low serum bicarbonate concentration and a
slight lowering of the bicarbonate reabsorption
threshold. We didn't attempt bicarbonate loading in
the patient under discussion because I didn't think
we stood to gain much from it.
DR. DERMOT MURNAGHAN (ConsultantNephrol-
ogist, Regional Hospital, Cork): Could you review
your thoughts regarding your patients in whom hy-
percalciuria persisted postoperatively? This finding
suggests that there is a primary renal calcium leak in
at least those patients.
DR. F. P. MULDOWNEY: Dr. Murnaghan's point
is well taken; to what extent does the hypercalciuria
persist in patients thought to have primary hyper-
parathyroidism despite removal of the adenoma? If
it persists, it might lead one to believe that the pri-
mary calcium leak was the first event that gave rise
to secondary hyperparathyroidism, which ultimate-
ly became autonomous and primary. Fair enough.
In our group of 15 patients, 12 patients did in fact
become normocalciuric and 3 remained hypercal-
ciuric following removal of the adenoma. Perhaps
your question recalls the data of Bordier in which
he demonstrated persistence of hypercalciuria in
patients following removal of the adenoma. But he
had loaded all of the patients with sufficient 25-hy-
droxy vitamin D prior to surgery to produce further
hypercalcemia and undoubtedly hypercalciuria. I
feel that such loading is really a gentle intoxication
and I suspect that the patients in our group would
have reacted with persistent hypercalciuria. Wheth-
er the hypercalciuria would have been due to the
intrinsic defect or to the vitamin D intoxication is
impossible to determine.
DR. DAVID POWELL (Consultant Endocrinolo-
gist, Mater Misericordiae Hospital, Dublin): We
are concerned with the difficulty in distinguishing
idiopathic hypercalciuria from mild primary hyper-
parathyroidism because of the substantial therapeu-
tic implications. We anticipate a low total serum
calcium concentration in patients with idiopathic
hypercalciuria, but a relatively elevated total serum
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calcium concentration, at least in the upper range of
normal, in patients with mild hyperparathyroidism.
You have shown that the mean total serum calcium
concentration is low in your patients with idiopathic
hypercalciuria but the ionized fraction is high. It ap-
pears that the total serum calcium concentration is
not a good reflection of the ionized serum calcium
concentration in patients with idiopathic hyper-
calciuria; there seems to be a slightly greater pro-
portion of total serum calcium in ionized form in
patients with idiopathic hypercalciuria than in con-
trol patients. I wonder if you could explain this in
physicochemical terms?
DR. F. P. MULDOWNEY: We wonder how to ex-
plain it too. There is no doubt that the patients with
idiopathic hypercalciuria [13] have a total serum
calcium concentration—9.4 0.4 mgIlOO mi—that
appears to be below the normal mean—9.8 0.4
mgIlOO ml—whereas the ionized serum calcium
concentration is above it. Whether this is a PTH-
induced effect or some totally unknown effect is not
clear, but the phenomenon is there and it is an im-
portant one.
DR. BRIAN KEOGH (Consultant Nephrolo gist,
Meath Hospital, Dublin): What are your thoughts
on screening for other factors that might be in-
volved in calicium stone formation, such as in-
creased urinary uric acid concentration or oxalate
excretion?
DR. F. P. MULDOWNEY: In screening patients we
do include the serum uric acid concentration, al-
though urinary uric acid concentration is not
sought. I am aware of the theory discussed by Coe
[23] that high urinary excretion of uric acid may
tend to "inhibit the inhibitors" of calcium crystali-
zation in the urine. The phenomenon appears to be
true but I have not yet found the information to be
meaningful in a diagnostic situation.
DR. J. T. HARRINGTON: You place a great deal of
weight on the results of the ionized serum calcium
determination in your evaluation of patients with
idiopathic hypercalciuria. In its absence would you
use parathyroid venous drainage localization stud-
ies either in primary hyperparathyroidism or in pa-
tients being re-operated?
DR. F. P. MULDOWNEY: We have used the local-
ization studies—that is, putting a catheter into the
venous drainage of the thyroid and parathyroid
areas—in a few situations. The patients in whom we
have used it are those in whom we have genuine
doubts whether hypercalcemia is of parathyroid ori-
gin or neoplastic origin. That is, of course, a totally
different situation than defining the origins of kid-
ney stones. Fortunately, hypercalcemia induced by
a PTH or PTH-like substance secreted from a tumor
does not usually last long enough to produce a renal
stone. I am a little worried about the venous cathe-
terization studies because they are rather complex
maneuvers in themselves. An excellent radiologist
and a catheterizer are required to do them, and the
procedure is rather lengthy. Surgical exploration for
parathyroid adenoma would seem to be as practical.
With the catheterization studies, it is not always
clear what might be the gradient in the venous efflu-
ent from a normal parathyroid gland compared with
a drainage of the venous effluent from, say, the thy-
roid. Perhaps Dr. Powell would comment on this
technique.
DR. D. POWELL: In patients with cancer-induced
hypercalcemia, we do not find high iPTH levels
[24], though we have performed catheter studies to
diagnose coincident hyperparathyroidism in a pa-
tient with cancer [25]. In patients with hyper-
parathyroidism, thyroid vein catheterization is a
little complex, certainly, and requires special radio-
logical skill. It is performed in the awake patient, is
not painful, causes no morbidity, and is a useful
pre-operative procedure for many patients with
overactive parathyroid glands.
To answer the query raised, we studied para-
thyroid gradients in thyroid veins in patients with
parathyroid disorders [26] and also in patients with-
out any calcium disorder [27]. Comparable gradi-
ents were found in both groups, though of course
absolute values were higher in those with over-
active parathyroids. So the size of the gradient is
not diagnostic but depends on the size of the vein
catheterized, and the degree of dilution of the gland
effluent. The major worth of the technique as a diag-
nostic tool is in patients with established hyper-
parathyroidism in whom bilateral thyroid vein gra-
dients indicate four-gland hyperplasia, whereas a
unilateral gradient—that is, no gradient on the other
side and thus a value the same as the peripheral lev-
el—indicates a single source of secretion, an ade-
noma, on the side of the gradient. This is the infor-
mation the surgeon needs.
DR. J. D0N0H0E: Dr. Muldowney, could you
comment on the present thinking regarding the im-
portance of "inhibitors" of stone formation in the
genesis and treatment of calcium stones? Also,
could you comment on the use of phosphate either
as sodium cellulose phosphate or orthophosphate in
the treatment of hypercalciuria?
DR. F. P. MULDOWNEY: Inhibitors of urinary
stone formation may act either at the point of cry s-
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tal formation or subsequently to prevent aggrega-
tion of these crystals. The subject has been dis-
cussed recently and placed in perspective by Fleish
[28], who has emphasized the in vitro character of
the evidence, and the important methodologic prob-
lems, not the least being the difficulty of repeating
with whole urine the data previously derived from
dilute solutions. The topic remains a theoretical
one, as yet difficult to transfer from bench research
to clinical evaluation or application. The simple fact
remains that supersaturation of the urine is deter-
mined in the main by calcium concentration and
secondarily by oxalate concentration [28].
Since urinary pyrophosphate is regarded as an in-
hibitor of stone formation, and since oral ingestion
of orthophosphate increases its excretion, this
mode of therapy has been employed by a number of
workers with varying interpretations [28]. Opinions
also vary concerning the important hazard of devel-
oping extraskeletal calcification [29, 30].
DR. J. T. HARRINGTON: Dr. Muldowney, what
are your thoughts on the importance of dietary ma-
nipulation in the treatment of idiopathic hyper-
calciuria?
DR. F. P. MULDOWNEY: Dietary restriction of
calcium is indicated in idiopathic hypercalciuria be-
cause urinary calcium may be reduced to values
found in control patients when dietary calcium is
restricted to 400 to 500 mg/day [31]. In practice, this
is readily achieved by avoiding dairy products such
as milk and cheese. The possible importance of so-
dium intake remains to be fully assessed, but re-
cently we have studied the effect of changing so-
dium intake from 60 to 200 mEq in two consecutive
3-day periods. On this regimen, six stone-forming
patients with previous inconstant hypercalciuria
with a random diet showed 24-hour urinary calcium
excretion to be in the range of 100 to 280 mg with an
intake of 60 mEq of sodium per day; this increased
to 260 to 550 mg with an intake of 200 mEq of
sodium per day on the third day. Clearly dietary so-
dium restriction may prove to be important. Car-
bohydrate intake has been shown to affect urinary
calcium in acute studies by Lemann, Peiring, and
Lennon [32], but more study is needed before car-
bohydrate restriction should be added to the grow-
ing number of dietary prohibitions in stone disease.
DR. D. POWELL: Dr. Muldowney, could you
comment on the alleged link between medullary
sponge kidney and hyperparathyroidism?
DR. F. P. MULDOWNEY: It is difficult to assign
importance to an association between two diseases
reported to coincide on relatively few occasions
[33—35]. If there is a causal relationship, the primary
event might be primary hyperparathyroidism lead-
ing to nephrocalcinosis and intersitital nephritis
with tubular ectasia, or alternatively a renal calcium
leak of sufficient severity to induce secondary hy-
perparathyroidism, ultimately going on to an auton-
omous or primary form.
DR. JOHN HARRINGTON: What are the indications
for surgery in patients with proven but marginal hy-
perparathyroidism? If such a patient has had only
one or two episodes of stone formation, are we jus-
tified in recommending surgery? Is there a role for
thiazides in this situation?
DR. F. P. MULDOWNEY: The patients with mar-
ginal hyperparathyroidism whom I have discussed
have had considerable difficulty with recurrent re-
nal colic and stones. In general, for this group of pa-
tients, I think it is best to remove the source of the
problem surgically, if one is sure of the diagnosis. A
strong point against the use of thiazides under these
circumstances is that more severe hypercalcemia
may result, and this may go unrecognized if the pa-
tient escapes medical supervision. If one could rely
on adequate follow-up—perhaps three or four times
a year—this approach might be acceptable. But, in
my experience, such patients tend not to return for
follow-up, so I think it is safer to advise surgery. On
the other hand, patients with marginal hyper-
parathyroidism who have not had recurrent stones
or renal colic can be managed conservatively—that
is, without surgery or thiazides.
Forum commentary
DR. FREDRIC L. COE Director, Division of Renal
Medicine, Michael Reese Hospital and Medical
Center, Chicago): Naturally, we are delighted that
Dr. Muldowney has found elevated fractional ex-
cretion of calcium in most cases of idiopathic hyper-
calciuria. This need not be primary evidence, how-
ever, for a renal leak in the sense that intestinal cal-
cium hyperabsorption could be thought of as
leading to chronic suppression of PTH secretion. If
increased fractional excretion of calcium can be
found to correlate with normal or high levels of
serum iPTH, then it seems difficult to escape the
conclusion that a renal leak must be present.
Although it has not been described in detail,
many published case series provide examples of
mild hypercalcemia in primary hyperparathyroid-
ism associated with marked hypercalciuria. The pa-
tient presented at this Forum appears to be an ex-
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ample of this phenomenon. Even though the in-
crease in apparent filtered load is not marked, it is
quite possible to have hypercalciuria, despite in-
creased rather than decreased calcium reabsorp-
tion. Fractional excretion of calcium is of course
the total urine calcium excretion divided by the
product of GFR and the ultrafilterable calcium con-
centration. Since the ultrafilterable calcium concen-
tration in primary hyperparathyroidism is common-
ly slightly above normal, the value for fractional
calcium excretion tends to be lower than the value
obtained by merely dividing calcium excretion by
GFR. In other words, it is possible to have marked
hypercalciuria with minimal hypercalcemia even in
the presence of slightly increased renal tubular cal-
cium reabsorption, and the increased calcium reab-
sorption is perfectly consistent with the known
physiological action of parathyroid hormone.
The probeim of serum parathyroid hormone lev-
els in idiopathic hypercalciuria has vexed many of
us. The actual prevalence of "high" values has var-
ied markedly with the immunoassay used. Perhaps
it is time that other criteria than the presence or ab-
sence of high serum iPTH levels be used to define
"renal" hypercalciuria. Although a renal leak theo-
ry tends to lead to the prediction of secondary hy-
perparathyroidism, might it not be worthwhile to
try to find more direct ways of diagnosing a renal
leak and then see what the iPTH levels are in pa-
tients who clearly have this abnormality?
As to the point raised by Dr. Muldowney that the
patients from my laboratory could have had pri-
mary hyperparathyroidism, I have some reserva-
tions. The serum calcium concentrations for these
patients were included in the original report. Virtu-
ally no values exceeded 10 mg/lOO ml, and every
patient was studied at least in triplicate; most had
quadruplicate samples. If we are to presume that
the patients we described had primary hyperpara-
thyroidism, then we are back to the old problem of
"normocalcemic" primary hyperparathyroidism,
something that Dr. Muldowney probably does not
endorse and that I find rather unsatisfactory as a
concept. Unlike 1,25-dihydroxy vitamin D, PTH
certainly does not augment urinary calcium excre-
tion when the serum calcium concentration is below
10 mg/l00 ml; it does in fact raise the fractional
reabsorption of calcium. For this reason, one would
have great difficulty explaining truly normocalcemic
hypercalciuria as a consequence of a primary in-
crease in PTH secretion. It is more likely that some
immunoassays tend to reflect higher values of serum
iPTH in idiopathic hypercalciuria than do others.
Reprint requests to Dr. Francis P. Muldowney, University
College and St. Vincent's Hospital, Dublin Ireland.
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